Wikidata

(Q40243206)

English

EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation

scientific article published on 15 August 2006

In more languages

Statements

title
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017
author name string
Jingxuan Pan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017
Alfonso Quintás-Cardama
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017
Cem Akin
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017
Peter Lamb
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017
publication date
15 August 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017
page(s)
315-322
1 reference
stated in
Europe PubMed Central
PubMed ID
16912224
retrieved
18 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40243206&oldid=2084883247"